Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

The microbiome may be linked to hair loss and could be a target for new treatments.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Two mouse mutations cause similar hair loss despite different skin changes.

Hair loss due to scarring can be treated by reducing inflammation, removing scar tissue, and transplanting hair. The Follicular Unit Extraction technique is effective but requires skill and time. Future focus should be on scar-less healing methods.

Combining FUE hair transplantation with PRP improves hair density and patient satisfaction in scarring alopecia.

Widened sweat ducts are a very specific sign of scarring hair loss.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Erlotinib can cause hair loss as a side effect.

Hair transplants for male baldness can show inflammation and fibrosis, but more research is needed to confirm LPP presence.

More research is needed to confirm PRP's effectiveness for scarring alopecia.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

Brunsting-Perry pemphigoid can cause scarring hair loss and may be underdiagnosed.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

A new method improves alopecia diagnosis using non-invasive steps.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

Accurate diagnosis and aggressive treatment are crucial to prevent permanent hair loss in cicatricial alopecia.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Two adults with unusual scalp fungus symptoms were successfully treated.

Dermatological conditions are complex and treatments often have mixed results.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Trichoscopy helps diagnose and treat dissecting cellulitis early, preventing scarring.